Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity

Kazunori Fujimoto1, Ryuta Koishi, Tetsuya Shimizugawa

  • 1Medicinal Safety Research Laboratories, Sankyo Co., Ltd., Fukuroi, Shizuoka, Japan.

Experimental Animals
|March 2, 2006
PubMed

Insights

Mice lacking Angiopoietin-like 3 (ANGPTL3) showed significantly lower blood triglyceride levels and reduced fat tissue. This was due to faster triglyceride clearance, indicating ANGPTL3 influences lipid metabolism and fat formation.

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Research

Background:

  • Angiopoietin-like 3 (ANGPTL3) is a protein involved in angiogenesis and lipid metabolism.
  • Understanding ANGPTL3's role is crucial for metabolic disease research.

Purpose of the Study:

  • To investigate the function of ANGPTL3 in lipid metabolism using a knockout mouse model.
  • To analyze the impact of ANGPTL3 deficiency on plasma lipids and adipose tissue.

Main Methods:

  • Generation of Angptl3-null mice.
  • Analysis of plasma lipid concentrations under normal and high-fat diets.
  • Measurement of epididymal adipose tissue weight and adipocyte size.
  • Triglyceride clearance studies and lipase activity assays.

Main Results:

  • Angptl3-null mice exhibited markedly low plasma triglyceride concentrations.
  • Reduced epididymal adipose tissue weight was observed in Angptl3-null mice on a high-fat diet.
  • Triglyceride clearance was accelerated in Angptl3-null mice, with increased lipoprotein lipase and hepatic lipase activities.

Conclusions:

  • ANGPTL3 plays a significant role in regulating lipid metabolism and triglyceride levels.
  • ANGPTL3 deficiency leads to enhanced triglyceride clearance and impacts adipose tissue formation.
  • These findings suggest ANGPTL3 as a potential therapeutic target for metabolic disorders.

Related Concept Videos